Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)

NCT06296056 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors
Metastatic

Interventions

BIOLOGICAL: Combi

Sponsor

Seoul Hospital